OKYO: OKYO Pharma Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 35.53
Enterprise Value ($M) 35.53
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-23 10,161 46,312 21.94
2025-01-22 7,907 37,013 21.36
2025-01-21 14,275 57,160 24.97

(click for more detail)

Similar Companies
OCEA – Ocean Biomedical, Inc. OCGN – Ocugen, Inc.
OCX – OncoCyte Corporation ONCO – Onconetix, Inc.
ONCY – Oncolytics Biotech Inc.


Financial data and stock pages provided by
Fintel.io